1. 853029-57-9
2. 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1h-purine-2,6(3h,7h)-dione
3. 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
4. 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1h-purine-2,6-dione
5. 8-bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
6. 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione
7. 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1h-purine-2,6-dione
8. 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1h-purine-2,6-dion
9. Schembl3919837
10. Dtxsid00647176
11. Bcp11833
12. Cs-m2881
13. Mfcd18642578
14. Zinc72190311
15. Akos016004953
16. Kg-0209
17. Ac-23922
18. Da-19419
19. Am20090703
20. Ft-0699074
21. A26902
22. F19248
23. J-519398
24. 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromo Xanthine
25. 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
26. 1-[(4-methyl-quinazolin-2yl) Methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromo-xanthine
27. 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-bromoxanthine
28. 1h-purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
29. 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1h-purine-2,6(3h,7h)-dione
30. 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1h-purine-2,6-dione
31. 8-bromo-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1h-purine-2,6(3h,7h)-dione
32. 8-bromo-7-(but-2-ynyl)-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
| Molecular Weight | 453.3 g/mol |
|---|---|
| Molecular Formula | C20H17BrN6O2 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 452.05964 g/mol |
| Monoisotopic Mass | 452.05964 g/mol |
| Topological Polar Surface Area | 84.2 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 735 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
SUPPLIERS
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
1-[(4-Methylquinazolin-2-yl)Methyl]-3-Methyl-7-(2-...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs) and ...
8-Bromo-7-(2-butynyl)-1-[(4-methylquinazolin-2yl)m...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, and S...
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(...
CAS Number : CAS-853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine chemic...
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazol...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high quality APIs and Intermed...
8-bromo-7-(but-2-ynyl)-3-methyl-1-((4-methylquinaz...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : CTX is one of the youngest and fastest-growing Indian API and Intermediate manufacturing companies doing business in over 70 countries. In these five years, all my thoughts and actions ...
1-{(4-methyl-quianazolin-2yl)methyl}-3-methyl-7- (...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Mehta API Pvt Ltd engaged in manufacturing and marketing of APIs & Advance Drug Intermediates.... Globally. Mehta Api has been inordinately proud of its achievements since its inception...
1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Morepen Laboratories Ltd.’ is 31 years old company. Went to public in 1993. Manufacturer and Exporter of complex and high margins molecules (APIs/Intermediates) for regulated markets ...
1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Pluvia Consumer Health is a multinational pharmaceutical company with its head office in Turkey/Istanbul & with unique molecules & know-how. Our portfolio contains several specific APIs...
8-Bromo-7-(but-2-ynyl)-3-methyl-1-((4- methylquina...
CAS Number : 853029-57-9
End Use API :
End Use API : Linagliptin
About the Company : Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for th...
END USE APIs
RELATED INTERMEDIATES
MARKET PLACE
LOOKING FOR A SUPPLIER?
